HomePress ReleaseOne80 Intermediaries Offers Liability Insurance for Chief Restructuring Officers

One80 Intermediaries Offers Liability Insurance for Chief Restructuring Officers

The policy covers gaps between the distressed company’s insurance and that of their Chief Restructuring Officer.

BOSTON–(BUSINESS WIRE)–One80 Intermediaries (One80), a specialty insurance broker headquartered in Boston, today announced the launch of its Chief Restructuring Officer Liability Insurance.


One80’s Private Equity and Transactional Liability Practice, along with its two highly rated carrier partners, have created a comprehensive insurance policy tailored to Chief Restructuring Officers (CROs), and their teams, as they work with distressed companies across a variety of industry classes. The policy offers limits of liability up to $30M and covers the restructuring firm as an additional insured.

CROs are typically responsible for the restructuring process of a distressed company, which allows the management team to focus on day-to-day operations. One80 protects the CRO and their team – given they may lack comprehensive coverage or are subject to high deductibles. Further the directors and officers policy limit for the distressed company is often exhausted and therefore will not cover the CRO.

RELATED:  Crush It Sports Lounge Announces Expansion with Crush It 2.0

“One80 is committed to providing highly specialized insurance solutions to executives and senior leaders across all industry classes,” said Matthew F. Power, President, One80 Intermediaries. “I am very proud of our Private Equity and Transactional Liability practice as they remain at the forefront of market intelligence and innovation, allowing us to provide our brokers and clients with best-in-class solutions,” he continued.

“The role of the CRO is not without significant risk given that by definition, the CRO is hired when a company is in distress. At One80 we understand the risks associated with this role and are excited to provide comprehensive coverage to address this gap in the market,” said Jonathan Legge, Senior Managing Director, One80 Intermediaries.

RELATED:  Epilepsy Drugs Market, Size, Global Research 2024-2030 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott Laboratories, Alkem Laboratories, Bausch, GSK, Novartis, and Pfizer - ResearchAndMarkets.com

About One80 Intermediaries

One80 Intermediaries is a privately held firm with offices throughout the US and Canada. As a leading insurance wholesaler and program manager, the company offers placement services and binding authority for property & casualty, professional and personal lines, life insurance, and travel/accident and health coverages. One80 specializes in key industry verticals such as medical stop loss, cannabis captives, alternative risk, warranty coverage and lender-based insurance. One80 serves commercial companies, non-profits, public entities, individuals and associations and unions, and has access to all major insurance markets in the US, Canada, and UK. One80 has offices in more than 40 locations in the US and Canada. For more information visit www.one80intermediaries.com.

RELATED:  IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease

Contacts

Media:

Lenika P. Milne

lmilne@one80intermediaries.com
(786) 865-4614



Keep exploring...

Related Articles

Luxury Cannabis Cigar Brand Launches Hand-Rolled Cannagar in New York Market

Colorado-Based Cannabis Brand, Made in Xiaolin, Expands Product Offerings to New York, Returns to...

Epilepsy Drugs Market, Size, Global Research 2024-2030 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott Laboratories, Alkem Laboratories, Bausch, GSK, Novartis, and Pfizer –...

DUBLIN--(BUSINESS WIRE)--The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight,...

NJOY Receives First FDA Authorizations for Menthol E-Vapor Products

RICHMOND, Va.--(BUSINESS WIRE)--$MO--Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food...

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the...

Life Is Chill Expands Line of THC Soft Gels with New Live Resin THC Capsules, A First Of Its Kind for the Arizona Market

The new plant-based soft gel will launch on Friday, January 19, providing Arizona consumers...

Find Your YAY! with the Launch of YAY!’s All-Natural, Plant-Based Product Line to Transform Sexual Wellness and Self-Care

WINCHESTER, Ky.--(BUSINESS WIRE)--YAY!, the brand daring to redefine sexual wellness and holistic self-care, is...